Alnylam Pharmaceuticals (ALNY) Financials

The income statement of Alnylam Pharmaceuticals Inc (ALNY) provides a detailed overview of the company's financial performance. It includes information on the company's revenue, expenses, and net income. The revenue represents the total amount of money generated by the company from its operations. It includes the sales of its products and services. The expenses include the cost of goods sold, research and development expenses, and selling, general, and administrative expenses. The net income is the final amount left after subtracting all the expenses from the revenue. It represents the profit or loss of the company.

The EBIT (earnings before interest and taxes) is a measure of the company's profitability. It is calculated by subtracting the operating expenses (excluding interest and taxes) from the gross profit. The EBITDA (earnings before interest, taxes, depreciation, and amortization) is a similar measure but takes into account the depreciation and amortization expenses as well. It provides a more accurate picture of the company's cash flow.

The gross profit represents the revenue minus the cost of goods sold. It indicates the profitability of the company's core operations. The net income from stockholders is the amount that remains after deducting all the expenses and taxes, and allocating the portion for the stockholders. It represents the return on investment for the stockholders.

The total revenue is the sum of all the revenue generated by the company across different product lines and services. It provides an overall picture of the company's financial performance. The balance sheet of Alnylam Pharmaceuticals Inc (ALNY) provides information about the company's financial position. It includes the assets, liabilities, and stockholders' equity. The assets represent what the company owns, such as cash, inventory, and property. The liabilities represent the company's obligations, such as loans and accounts payable. The stockholders' equity represents the amount of money invested by the stockholders.

The cash equivalents are the short-term investments that can be easily converted into cash. They provide the company with liquidity and flexibility. The net debt is the difference between the total debt and the cash equivalents. It indicates the company's ability to meet its financial obligations. The stockholders' equity is the amount of money invested by the stockholders. It represents their ownership stake in the company.

The total assets include both the current and non-current assets of the company. They represent the resources owned by the company. The total debt includes both the short-term and long-term liabilities of the company. It indicates the company's financial leverage. The total liabilities represent the company's financial obligations. They include both the current and non-current liabilities.

The cash flow statement of Alnylam Pharmaceuticals Inc (ALNY) provides information about the cash inflows and outflows of the company. It includes the cash generated from operating activities, investing activities, and financing activities. The operating cash flow represents the cash generated from the company's core operations. The investing cash flow represents the cash used for investing activities, such as acquiring new assets. The financing cash flow represents the cash used for financing activities, such as raising capital.

The free cash flow is the cash left after deducting the capital expenditures from the operating cash flow. It represents the cash available for distribution to the stockholders or reinvestment in the business. Overall, the financial statements provide valuable information about the financial performance and position of Alnylam Pharmaceuticals Inc (ALNY).